MALIGNANT OVARIAN TUMORS DIAGNOSTICS DIFFICULTIES-Reference-Cited by-同舟云学术

MALIGNANT OVARIAN TUMORS DIAGNOSTICS DIFFICULTIES

Published:2018-08-15 Issue:2 Volume:14 Page:82-89
ISSN:1999-8627
Container-title:Tumors of female reproductive system
language:
Short-container-title:Tumors of female reproductive system

Author:

Nikoghosyan S. O.,Zagashtokov A. Z.,Levchenko N. E.,Thakokhov M. M.

Abstract

Despite the undeniable successes of modern medicine, the problems of oncology and, in particular, oncogynecology are still unresolved. Thus, a 5-year overall survival rate for stage I ovarian cancer is 89 %, for stage IV – 17 %. Given that complaints in patients with ovarian cancer appear only after the tumor has passed beyond the organ, the most important and key factor in successful treatment is the correct diagnosis of ovarian neoplasm. Observance of the correct algorithm and correct surgery can significantly improve the results of treatment. The article will discuss the difficulties of diagnosing ovarian cancer.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Obstetrics and Gynaecology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference33 articles.

1. De Angelis R., Sant M., Coleman M.P. et al. Cancer survival in Europe 1999– 2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014;15(1):23–34. PMID: 24314615. DOI: 10.1016/S1470- 2045(13)70546-1.

2. Baldwin L.A., Huang B., Miller R.W. et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol 2012;120(3):612–8. PMID: 22914471. DOI: 10.1097/AOG.0b013e318264f794.

3. Flam F., Einhorn N., Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1988;27(1):53–7. PMID: 3338609.

4. ACOG Committee on Gynecologic Practice. The role of the generalist obstetriciangynecologist in the early detection of ovarian cancer. Gynecol Oncol 2002;87(3):237–9. PMID: 12492084.

5. Walker J.L., Powell C.B., Chen L.M. et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer 2015;121(13):2108–20. PMID: 25820366. DOI: 10.1002/ cncr.29321.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The structure of disability due to malignant neoplasms of the reproductive system in terms of severity in the comparative aspect of the medical and social characteristics of women with disabilities;Medical and Social Expert Evaluation and Rehabilitation;2023-11-29

2. The importance of the regularity of preventive examinations in the early diagnosis of ovarian cancer;Perm Medical Journal;2023-06-02

3. RADIATION DIAGNOSIS OF SEROUS CARCIONEOMA OF THE OVARY OF ENORMOUS SIZE IN A PATIENT OF POSTMENOPAUSAL AGE (CLINICAL CASE);Acta medica Eurasica;2023-03-30

4. Analysis of echographic signs of ovarian tumors;Medical Visualization;2022-06-15

5. A new algorithm to assess the risk of malignancy in premenopausal patients with pelvic mass;Tumors of female reproductive system;2022-05-08